24/7 Patient Assistance: 760-405-8205

Helen J. Ross, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma

  • Bio & Insurance Information

    Dr. Helen Ross is a medical oncologist in Phoenix, Arizona. She got her medical degree from Revelle College, and did her internship at University of California, Los Angeles. At the Department of Medicine, University of California, Dr. Ross completed her fellowship in hematology/ocology. She is board certified in both internal medicine and medical oncology. Dr. Ross is currently affiliated with Mayo Clinic – Phoenix and Mayo Clinic – Scottsdale.


    Insurance Accepted

    MultiPlanUnitedHealthcare


  • Education & Training

    dept_icon

    Revelle College, University of California, San Diego

    Medical School

    dept_icon

    University of California, Los Angeles

    Internship

    dept_icon

    University of California, Los Angeles

    Residency

    dept_icon

    Department of Medicine, University of California, Los Angeles

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Mayo Clinic Phoenix

    Languages: English/Spanish

    480-515-6296

    5777 East Mayo Boulevard

    Phoenix, Arizona 85054

    Read More

    Mayo Clinic Scottsdale

    Languages: English/Spanish

    480-301-8000

    13400 E Shea Blvd

    Scottsdale, Arizona 85259

    Read More
  • Publications & Memberships

    Dr. Helen J. Ross has contributed to 3 publications.

    A new scoring system for predicting survival in patients with non-small cell lung cancer.

    Schild SE, Tan AD, Wampfler JA, Ross HJ, Yang P, Sloan JA.

    See more >>

    PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-c

    Zinner RG1, Obasaju CK, Spigel DR, Weaver RW, Beck JT, Waterhouse DM, Modiano MR, Hrinczenko B, Nikolinakos PG, Liu J, Koustenis AG, Winfree KB, Melemed SA, Guba SC, Ortuzar WI, Desaiah D, Treat JA, Govindan R, Ross HJ.

    See more >>

    Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck.

    Curtis KK, Wong WW, Ross HJ.

    See more >>

    Memberships

    American Association for Cancer Research

    American Society of Clinical Oncology